Pancreatic β-cell growth and survival in the onset of type 2 diabetes: A role for protein kinase B in the Akt?

American Journal of Physiology - Endocrinology and Metabolism

Volumn 287, Issue 2 50-2, 2004, Pages

  Dickson, Lorna M ^a   Rhodes, Christopher J ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Insulin receptor substrate 2; Obesity; Protein kinase B substrates

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 2; PROTEIN KINASE B;

APOPTOSIS; CELL GROWTH; CELL SURVIVAL; GLUCOSE HOMEOSTASIS; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; APOPTOSIS; CELL SURVIVAL; DIABETES MELLITUS, TYPE 2; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; MICE; OBESITY; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION;

EID: 3242656480     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00031.2004     Document Type: Review

References (62)

1. Boden G and Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32, Suppl 3: 14-23, 2002.
2. Bonner-Weir S. Life and death of the pancreatic beta cells. Trends Endocrinol Metab 11: 375-378, 2000.
3. Bonner-Weir S. Perspective: postnatal pancreatic beta cell growth. Endocrinology 141: 1926-1929, 2000.
4. Briaud I, Lingohr MK, Dickson L, Wrede C, and Rhodes CJ. Differential activation mechanisms of Erk-1/2 and p70S6K by glucose in pancreatic β-cells. Diabetes 52: 974-983, 2003.
5. Buteau J, Foisy S, Rhodes CJ, Carpenter L, Biden TJ, and Prentki M. Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation. Diabetes 50: 2237-2243, 2001.
6. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, and Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110, 2003.
7. Butler AE, Janson J, Soeller WC, and Butler PC. Increased beta cell apoptosis prevents adaptive increase in beta cell mass in a mouse model of type-2 diabetes; evidence for a role of islet amyloid formation rather than a direct action of amyloid. Diabetes 52: 2304-2314, 2003.
8. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, and Reed JC. Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321, 1998.
9. Chan TO, Rittenhouse SE, and Tsichlis PN. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Annu Rev Biochem 68: 965-1014, 1999.
10. Cohen P and Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol 2: 769-776, 2001.
11. Dahl U, Sjodin A, and Semb H. Cadherins regulate aggregation of pancreatic beta-cells in vivo. Development 122: 2895-2902, 1996.
12. Dan HC, Sun M, Kaneko S, Feldman RI, Nicosia SV, Wang HG, Tsang BK, and Cheng JQ. Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem 279: 5405-5412, 2004.
13. Dickson LM, Lingohr MK, McCuaig J, Hugl SR, Snow L, Kahn BB, Myers MG Jr, and Rhodes CJ. Differential activation of protein kinase B and p70(S6)K by glucose and insulin-like growth factor 1 in pancreatic beta-cells (INS-1). J Biol Chem 276: 21110-21120, 2001.
14. Diehl JA, Cheng M, Roussel MF, and Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-3511, 1998.
15. Dumonteil E and Philippe J. Insulin gene: organisation, expression and regulation. Diabetes Metab 22: 164-173, 1996.
16. Gilley J, Coffer PJ, and Ham J. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 162: 613-622, 2003.
17. Halban PA, Powers SL, George KL, and Bonner-Weir S. Spontaneous reassociation of dispersed adult rat pancreatic islet cells into aggregates with three-dimensional architecture typical of native islets. Diabetes 36: 783-790, 1987.
18. Hales CN and Barker DJ. The thrifty phenotype hypothesis. Br Med Bull 60: 5-20, 2001.
19. Hennige AM, Burks DJ, Ozcan U, Kulkarni RN, Ye J, Park S, Schubert M, Fisher TL, Dow MA, Leshan R, Zakaria M, Mossa-Basha M, and White MF. Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest 112: 1521-1532, 2003.
20. Jetton TL, Liu YQ, Trotman WE, Nevin PW, Sun XJ, and Leahy JL. Enhanced expression of insulin receptor substrate-2 and activation of protein kinase B/Akt in regenerating pancreatic duct epithelium of 60%-partial pancreatectomy rats. Diabetologia 44: 2056-2065, 2001.
21. Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J, Walker J, Lin X, White M, and Montminy M. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 17: 1575-1580, 2003.
22. Johnson JD, Ahmed NT, Luciani DS, Han Z, Tran H, Fujita J, Misler S, Edlund H, and Polonsky KS. Increased islet apoptosis in Pdx1+/-mice. J Clin Invest 111: 1147-1160, 2003.
23. Khoo S, Griffen SC, Xia Y, Baer RJ, German MS, and Cobb MH. Regulation of insulin gene transcription by ERK1 and ERK2 in pancreatic beta cells. J Biol Chem 278: 32969-32977, 2003.
24. Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs WH III, Wright CV, White MF, Arden KC, and Accili D. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110: 1839-1847, 2002.
25. Kushner JA, Ye J, Schubert M, Burks DJ, Dow MA, Flint CL, Dutta S, Wright CV, Montminy MR, and White MF. Pdx1 restores beta cell function in Irs2 knockout mice. J Clin Invest 109: 1193-1201, 2002.
26. Kwon G, Pappan KL, Marshall CA, Schaffer JE, and McDaniel ML. cAMP dose-dependently prevents palmitate-induced apoptosis by both protein kinase A- and cAMP-guanine nucleotide exchange factor-dependent pathways in beta-cells. J Biol Chem 279: 8938-8945, 2004.
27. Li Y, Hansotia T, Yusta B, Ris F, Halban PA, and Drucker DJ. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J Biol Chem 278: 471-478, 2003.
28. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E, and Slingerland JM. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8: 1153-1160, 2002.
29. Lingohr MK, Buettner R, and Rhodes CJ. Pancreatic beta-cell growth and survival - a role in obesity-linked type 2 diabetes? Trends Mol Med 8: 375-384, 2002.
30. Lingohr MK, Dickson LM, McCuaig JF, Hügl SR, Twardzik DR, and Rhodes CJ. Activation of IRS-2 mediated signal transduction by IGF-1, but not TGF-a or EGF, augments pancreatic β-cell proliferation. Diabetes 51: 966-976, 2002.
31. Lingohr MK, Dickson LM, Wrede C, McCuaig JF, Myers MG Jr, and Rhodes CJ. IRS-3 inhibits IRS-2-mediated signaling in pancreatic β-cells. Mol Cell Endocrinol 204: 85-89, 2003.
32. Lingohr MK, Dickson LM, Wrede CE, Briaud I, McCuaig JF, Myers MG Jr, and Rhodes CJ. Decreasing IRS-2 expression in pancreatic β-cells (INS-1) promotes apoptosis, which can be compensated for by introduction of IRS-4 expression. Mol Cell Endocrinol 209: 17-31, 2003.
33. Liston P, Fong WG, and Korneluk RG. The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22: 8568-8580, 2003.
34. Liu YQ, Jetton TL, and Leahy JL. β-Cell adaptation to insulin resistance. Increased pyruvate carboxylase and malate-pyruvate shuttle activity in islets of nondiabetic Zucker fatty rats. J Biol Chem 277: 39163-39168, 2002.
35. Mayo LD and Donner DB. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci USA 98: 11598-11603, 2001.
36. McDaniel ML, Marshall CA, Pappan KL, and Kwon G. Metabolic and autocrine regulation of the mammalian target of rapamycin by pancreatic beta-cells. Diabetes 51: 2877-2885, 2002.
37. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, and Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 286: 1195-1200, 2001.
38. Pick A, Clark J, Kubstrup C, Levisetti M, Pugh W, Bonner-Weir S, and Polonsky KS. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes 47: 358-364, 1998.
39. Plesner A, Korneluk RG, Liston P, Tan R, and Verchere CB. The X-linked inhibitor of apoptosis protein (XIAP) protects transformed β-cells from cytokine-mediated killing and prolongs murine islet allograft survival (Abstract). Diabetes 51: A41, 2002.
40. Poitout V and Robertson RP. Minireview: Secondary beta-cell failure in type 2 diabetes - a convergence of glucotoxicity and lipotoxicity. Endocrinology 143: 339-342, 2002.
41. Portha B, Giroix MH, Serradas P, Gangnerau MN, Movassat J, Rajas F, Bailbe D, Plachot C, Mithieux G, and Marie JC. β-Cell function and viability in the spontaneously diabetic GK rat: information from the GK/Par colony. Diabetes 50, Suppl 1: S89-S93, 2001.
42. Rane SG and Reddy EP. Cell cycle control and pancreatic β-cell proliferation. Front Biosci 5: 1-19, 2000.
43. Rena G, Guo S, Cichy SC, Unterman TG, and Cohan P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 274: 17179-17183, 1999.
44. Rhodes CJ and White MF. Molecular insights into insulin action and secretion. Eur J Clin Invest 32, Suppl 3: 3-13, 2002.
45. Robertson RP, Davis C, Larsen J, Stratta R, and Sutherland DE. Pancreas and islet transplantation for patients with diabetes. Diabetes Care 23: 112-116, 2000.
46. Rossig L, Badorff C, Holzmann Y, Zeiher AM, and Dimmeler S. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation. J Biol Chem 277: 9684-9689, 2002.
47. Scaglia L, Smith FE, and Bonner-Weir S. Apoptosis contributes to the involution of beta cell mass in the post partum rat pancreas. Endocrinology 136: 5461-5468, 1995.
48. Shafrir E, Ziv E, and Mosthaf L. Nutritionally induced insulin resistance and receptor defect leading to beta-cell failure in animal models. Ann NY Acad Sci 892: 223-246, 1999.
49. Sherr CJ. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2: 731-737, 2001.
50. Sorenson RL and Brelje TC. Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29: 301-307, 1997.
51. Staal SP. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci USA 84: 5034-5037, 1987.
52. Stratford S, DeWald DB, and Summers SA. Ceramide dissociates 3′-phosphoinositide production from pleckstrin homology domain translocation. Biochem J 354: 359-368, 2001.
53. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, and Birnbaum MJ. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med 7: 1133-1137, 2001.
54. Unger RH and Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 15: 312-321, 2001.
55. Wang Q, Li L, Xu E, Wong V, Rhodes CJ, and Brubaker PL. Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells. Diabetologia 47: 478-487, 2004.
56. Wicksteed BL, Alarcón C, Briaud I, Lingohr MK, and Rhodes CJ. Glucose-induced translational control of proinsulin biosynthesis is proportional to preproinsulin mRNA levels in islet β-cells but not regulated via a positive feedback of secreted insulin. J Biol Chem 278: 42080-42090, 2003.
57. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, and White MF. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet 23: 32-40, 1999.
58. Withers DJ, Gutierres JS, Towery H, Ren JM, Burks DJ, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, and White MF. Disruption of IRS-2 causes type-2 diabetes in mice. Nature 391: 900-904, 1997.
59. Wrede C, Dickson LM, Lingohr MK, Briaud I, and Rhodes CJ. Modulation of mitogenic signaling pathways by conventional and novel protein kinase-C isoforms in pancreatic β-cells (INS-1). J Mol Endocrinol 30: 271-286, 2003.
60. Wrede CE, Dickson LM, Lingohr MK, Briaud I, McCuaig JF, and Rhodes CJ. Protein kinase B/Akt prevents fatty acid induced apoptosis in pancreatic beta-cells (INS-1). J Biol Chem 277: 49676-49684, 2002.
61. L in β-cells prevents cell death but impairs mitochondrial signal for insulin secretion. Am J Physiol Endocrinol Metab 278: E340-E351, 2000.
62. Zimmet P, Alberti KG, and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414: 782-787, 2001.